Kaps3

Surendranagar, India Founded: 2018 • Age: 8 yrs
Pharmaceutical product manufacturing and distribution in India.
Annual revenue $1.5M Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Kaps3

Kaps3 is a company based in Surendranagar (India) founded in 2018. Kaps3 offers products and services including BRONCOZA and ESOCITA-C TAB.

  • Headquarter Surendranagar, India
  • Sectors
    Healthcare
  • Phone
    Locked
  • Social
    Locked
  • Legal Name Kaps Three Life Sciences Private Limited
  • Date of Incorporation 23 Nov, 2011
  • Jurisdiction Surendranagar, Gujarat, India
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $1.48 M (USD)
    -1.57
    as on Mar 31, 2023
  • Net Profit
    $11.33 K (USD)
    -53.86
    as on Mar 31, 2023
  • EBITDA
    $16.86 K (USD)
    108.92
    as on Mar 31, 2023
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Kaps3

Kaps3 offers a comprehensive portfolio of products and services, including BRONCOZA and ESOCITA-C TAB.

Product name locked
Category locked
Primary

A non-addictive antitussive medication that is used for dry coughs

Product name locked
Category locked
Locked

A product that is provided for health purposes, as indicated in product updates

Funding Insights of Kaps3

Premium access

Detailed funding history for Kaps3

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Kaps3

Investments
Premium access

Investment portfolio details for Kaps3

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Kaps3

Premium access

Detailed financials for Kaps3

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Kaps3 Comparisons

Kaps3 Primary company
Description
Pharmaceutical product manufacturing and distribution in Ind...
Location
Surendranagar, India
Founded Year
2018
Annual Revenue
$1.48 M (USD)
Net Profit
$11.33 K (USD)
EBITDA
$16.86 K (USD)
Employees
Not available
Premium access

Peer comparison for Kaps3

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Kaps3

Premium access

Detailed competitors of Kaps3

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Kaps3

Premium access

Complete news archive for Kaps3

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kaps3

Kaps3 was founded in 2018.

Kaps3 is headquartered in Surendranagar, India. It is registered at Surendranagar, Gujarat, India.

Annual revenue of Kaps3 is $1.48M as on Mar 31, 2023.

Kaps3 Lifesciences Pvt. Ltd. is recognized as a rising entity in the pharmaceutical sector, having been established through the collaborative efforts of six professionals. A commitment to providing high-quality products at affordable rates is maintained, with strict quality checks performed by experienced teams to ensure adherence to international standards. Innovative efforts are focused on product development and packaging, leading to the companys rapid gain of market position. A wide range of pharmaceutical offerings, including treatments for coughs and other conditions, is provided, contributing to its prominence within a short period.

Kaps3 offers BRONCOZA and ESOCITA-C TAB.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available